STOCKS TELEGRAPH

Tag: CERN

  • Takeover Talks: Cerner Corporation (CERN) stock Soars High Pre-Market

    Cerner Corporation (CERN) stock gained a huge 19% in the premarket hours amid speculations of Oracle’s takeover talks of the company.

    During regular trading, the stock barely kept in the green with a small gain of 0.72% at its close of $79.49. Following the emergence of the news in the premarket today, the stock jumped up to $95.

    The medical records company Cerner Corporation has a market capitalization of $23.22 billion, Currently, the company has 294.22 million outstanding shares in the market.

    What is Happening?

    On December 16, news emerged that Oracle Corp. is in talks for the takeover of CERN at about $30 billion. According to Wall Street Journal, the company might soon reach a deal. Furthermore, if the deal goes through, it would be Oracle’s biggest acquisition to date. Moreover, Oracle is the second-largest software company by revenue and market capitalization.

    The emergence of the news caused CERN stock to rally big in the after hours. Hence, it crossed its 52-week high of $84.20, as it reached $97.50. Previously, the stock had attained the 52-week high on January 28, 2021. Currently, it has reached well beyond the 52-week high which will be marked as the new high aftermarket opens on Friday. Further, there is sure enough possibility of the stock crossing the current value if it did not fall under corrections soon.

    CERN’s Quarterly Dividends

    On December 10, the company announced increased quarterly dividends. As per the announcement, CERN’s board of directors issued a quarterly dividend of $0.27 per outstanding share. This shows an increase of 23% from the previous quarter’s dividend of $0.22. Moreover, the record date for shareholders for the dividend is December 27, 2021. Further, the cash dividend will be payable on January 11, 2022.

    Financial Analysis

    On October 29, 2021, the company declared its financial results for the third quarter of 2021. The Q3 ended on September 30, 2021. In the third quarter of 2021, CERN generated revenue of $1.468 billion, against $1.369 billion in Q3 of 2020. This marked an increase of 7% year-over-year. Further, the third quarter’s revenue beat the consensus estimate by 1.16%.

    Moreover, the adjusted non-GAAP diluted earnings per share were $0.86 in the third quarter of 2021. This shows an increase of 19% from $0.72 in the third quarter of 2020. Further, the earnings per share also beat the consensus estimate of $0.82 for the quarter.

  • Early Morning Vibes: Top 4 Stocks To Watch Right Now

    Early Morning Vibes: Top 4 Stocks To Watch Right Now

    For Martin Luther King Day, the U.S. treasuries were closed yesterday. In the meantime, on Wednesday, the Americans are waiting for the unveiling of Joe Biden. In the run-up to that time, a $1900 billion corona support plan was already revealed. Janet Yellen, Minister of Economy, also accepts. The former Fed Chairman suggests that a massive boost can be used to generate the existing low-interest rates.

    The future of New York is now pointed to a higher start. The S&P future is 0.48% higher and the Nasdaq trading is even 0.80% higher. The annual findings of Bank of America and Goldman Sachs will be revealed this afternoon at 1 p.m. It’s the turn of Netflix after the closure at 10:00 PM. In the fourth quarter of 2020, JPMorgan Chase analysts plan to welcome 6 million users on the subscription site.

    Today Top Movers

    DBV Technologies (DBVT), a biotechnology company, rose about 37.99% ‎at $7.81 in pre-market trading Tuesday after it declared the receipts of written responses from the FDA to the question asked for the ‎Type A request the company submitted in Oct 2020.

    Gevo Inc (GEVO) share price climbed 39.22% to $8.91 during early morning ‎trading session on Tuesday.‎ The company will participate in Water Tower Research Fireside Chat Series on Thursday, January 21, 2021 at 3:00 pm EST.

    Nio Inc (NIO) stock escalated 4.37% at $58.73 in the pre-‎market trading today after declaring the closing of US$1.5 billion convertible senior notes.

    Castor Maritime Inc (CTRM) hiked over 8.10% at $0.36 in pre-market ‎trading on Tuesday.‎

    Top Upgrades & Downgrades

    KeyBanc turned bullish on Facebook Inc. (FB), upgrading the stock to “Overweight” and assigning a $345.0 price target, representing a potential upside of 29.3% from Friday’s close.

    Darden Restaurants Inc. (DRI) has won the favor of Morgan Stanley’s equity research team. The firm upgraded the shares from Equal-Weight to Overweight and moved their price target to $142.0, suggesting 17.23% additional upside for the stock. 

    Arch Capital Group Ltd. (ACGL) received an upgrade from analysts at JMP Securities. They changed their rating on ACGL to Market Outperform from Market Perform in a recently issued research note. 

    Earlier Tuesday BofA reduced its rating on Acadia Realty Trust (NYSE: AKR) stock to Neutral from Buy and assigned the price target to $17.50. 

    BofA analysts reduced their investment ratings, saying in research reports covered by the media that it’s rating for Premier Inc (NASDAQ: PINC) has been changed to Underperform from Buy and the new price target is set at $36. 

    Analysts at BofA downgraded Cerner Corporation (NASDAQ: CERN)’s stock to Underperform from Buy Tuesday.

    Latest Insider Activity

    TransEnterix Inc. (TRXC) Director Milne David Bruce announced the sale of shares taking place on Jan 15 at $2.10 for some 147,058 shares. The total came to more than $0.31 million.

    Inovio Pharmaceuticals Inc. (INO) CFO KIES PETER sold on Jan 15 a total of 119,290 shares at $10.02 on average. The insider’s sale generated proceeds of almost $0.3 million. 

    Amicus Therapeutics Inc. (FOLD) Director WHITMAN BURKE W declared the purchase of shares taking place on Jan 04 at $23.17 for some 1,500 shares. The transaction amount was around $34755. 

    C.H. Robinson Worldwide Inc. (CHRW) Director SHORT BRIAN bought on Jan 04 a total 21,843 shares at $93.58 on average. The purchase cost the insider an estimated $5,159.

    Important Earnings

    Top US earnings releases scheduled for today include Bank of America Corporation (NYSE: BAC). It will announce its Dec 2020 financial results. The company is expected to report earnings of $0.55 per share from revenues of $20.68B in the three-month period.

    Analysts expect Halliburton Company (NYSE: HAL) to report a net income (adjusted) of $0.15 per share when the bank releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $3.21B.

    Netflix Inc. (NFLX), due to announce earnings after the market closes today, is expected to report earnings of $1.39 per share from revenues of $6.63B recently concluded three-month period.

  • 13 Trending Stocks in Health Information Services Industry

    13 Trending Stocks in Health Information Services Industry

    As investors weighed the stimulus vote of Monday against the emergence of a new ‎coronavirus strain ‎in the UK, US equities ended mixed on Tuesday.
‎

    The Senate approved the measure Monday night after months of negotiations over ‎additional fiscal ‎support. The bill funds the government through September 30 and includes ‎a new stimulus of $900 ‎billion. Also, the package includes $300 in additional federal ‎unemployment benefits and $600 in direct ‎payments. 
‎

    Some of the key players in the Health Information Services sector were:

‎‎

    NantHealth Inc. (NASDAQ:NH) shares were trading up 21.50% at $3.56 at the ‎time of writing on Tuesday.‎

    NantHealth Inc. (NASDAQ:NH) share price went from a low point around $0.92 ‎to briefly over $6.60 in past 52 weeks, though shares have since pulled back to $3.56. NH market cap ‎has remained high, hitting $427.88M at the time of writing, giving it price-to-sales ratio of more than ‎‎5.

    ‎If we look at the recent analyst rating NH, Canaccord Genuity reiterated ‎coverage on NH shares with a Buy rating and a $3.75 price target, which implies ‎room for 0.19% upside momentum this year.

    HMS Holdings Corp. (HMSY) last closed at $36.58, in a 52-week range of $18.19 ‎to $36.75. The company recently reported an agreement with Veritas Capital-backed Gainwell ‎Technologies, whereby Gainwell will acquire HMS. Analysts have a consensus price target of ‎‎$35.09.

    Teladoc Health Inc. (TDOC) stock soar by 3.15% to $206.04. The most recent ‎rating by Evercore ISI, on December 22, 2020, is at an In-line.

    American Well Corporation (NYSE:AMWL) Shares headed rising, higher as much ‎as 5.90%. The most recent rating by Stifel, on December 18, 2020, is at a Hold.

    Veeva Systems Inc. (NYSE:VEEV) rose 5.76% after gaining more than $15.61 on ‎Tuesday. Veeva reported on December 15, 2020, that Integra LifeSciences has selected Veeva Vault ‎CDMS for clinical data management. ‎

    Change Healthcare Inc. (CHNG) last closed at $18.83, in a 52-week range of ‎‎$6.18 to $18.70 following the announcement of successful introduction of its first cloud-based medical ‎tools for radiologists and other specialties along with its roadmap to help healthcare organizations ‎begin their migration of medical imaging to the cloud. Analysts have a consensus price target of ‎‎$20.39.

    GoodRx Holdings Inc. (GDRX) stock soar by 3.49% to $48.32 after announcing ‎recognition from workplace culture site Comparably for its company culture and leadership. The most ‎recent rating by RBC Capital Mkts, on November 19, 2020, is at an Outperform.

    Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) Shares headed rising, ‎higher as much as 2.15%. The company announced on December 17, 2020, that it is dedicating ‎extensive resources to ensure its clients are prepared to maximize functionality within its solutions to ‎respond to the COVID-19 pandemic. The most recent rating by Argus, on November 11, 2020, is at a ‎Buy.

    HealthEquity Inc. (NASDAQ:HQY) rose 2.27% after gaining more than $1.51 on ‎Tuesday. The company reported on December 8, 2020, that revenue for the third quarter ended ‎October 31, 2020 of $179.4 million grew 14% compared to $157.1 million for the third quarter ended ‎October 31, 2019.

    ‎Cerner Corporation (CERN) last closed at $77.38, in a 52-week range of $53.08 to ‎‎$80.90. The firm on December 16, 2020 revealed an agreement to acquire health division of Kantar. ‎Analysts have a consensus price target of $78.23.

    ‎1Life Healthcare Inc. (ONEM) stock soar by 3.97% to $43.26. The most recent ‎rating by Credit Suisse, on October 30, 2020, is at an Outperform.

    ‎So-Young International Inc. (NASDAQ:SY) Shares headed falling, lower as much ‎as -7.41%. The most recent rating by Deutsche Bank, on April 23, 2020, is at a Buy.

    ‎Schrodinger Inc. (NASDAQ:SDGR) rose 0.85% after gaining more than $0.7 on ‎Tuesday.

  • Major General Elder Granger, M.D., U.S. Army (Retd) joins Cerner board of directors

    Cerner Corporation (CERN) expands its board of directors by appointing Major General Elder Granger, M.D., U.S. Army (Retd) to the company’s Board of Directors, from November 16, 2020. Dr Granger, who is 67 years old is currently

    Cerner’s chairman and chief executive officer, Brent Shafer said that it is an honour to welcome Dr Granger to our Board. He has a proven experience as a clinical, military and business leader and he will bring invaluable insights to Cerner particularly in the commercial and federal health sectors.

    The Cerner now has 11 members on his board. Dr Granger will be Class II Directorand will stand for re-election at Cerner’s 2021 annual shareholder meeting.

    Dr Granger, who is 67 years old is currently the president and CEO of The 5Psa health care, education and leadership consulting organization. He served in the U.S army for over 35 years. He worked on important roles such as deputy director and program executive officer of the TRICARE Management ActivityOffice of the Assistant Secretary of Defense (Health Affairs) in Washington, D.C. He has led at every level of the Army Medical Department. He is also board-certified by the American Board of Internal Medicine and the Board of Hematology and Oncology, a certified physician executive by the Certifying Commission in Medical Management, certified by the American College of Healthcare Executives and certified in Medical Quality by the American Board of Medical Quality. He has earned the CERT Certificate in Cybersecurity Oversight from Carnegie Mellon University, certified in Healthcare Compliance by Health Care Compliance Association and is a certified Compliance Officer by American Academy of Professional Coders. Dr Granger also serves on the boards of directors of Cigna Corporation.